FDA
-
-
-
-
-
-
-
Guardant Health (GH) PT Raised to $175 at Mizuho
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Guardant Health (GH) Following G360 Liquid FDA Approval
-
-
-
-
-
-
-
'Guardant Health (GH) is our top growth idea'; PT Lowered to $120 at TD Cowen
-
-
-
-
-
-
-
Actor and Cancer Advocate Patrick Dempsey Partners with Guardant Health to Raise Awareness about Colorectal Cancer Screening and Shield Blood Test, Sharing His Experience Getting Screened
-
-
-
-
-
-
-
Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients
-
-
-
-
-
-
-
Former health secretary Alex Azar joins Guardant Health board
-
-
-
-
-
-
-
Guardant Health reports improved Shield cancer test performance
-
326,431 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

